Reopro and pharmaceutical product counterfeit Patient Reports March 22, 2010

Reopro Side Effects Report #5787037-5
Reopro side effect was reported by a Physician from MEXICO on June 18, 2008. Male patient, 50 years of age, was diagnosed with thrombosis and was treated with Reopro. After drug was administered, patient experienced the following side effects: coronary artery restenosis, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: 16 OR 17 ML EVERY HOUR. During the same period patient was treated with MIDAZOLAM, FENTANYL. Patient was hospitalized. Patient died on 04/07/2008.

Reopro Side Effects Report #5787038-7
Reopro side effect was reported by a Physician from MEXICO on June 18, 2008. Male patient, 50 years of age, was diagnosed with thrombosis and was treated with Reopro. After drug was administered, patient experienced the following side effects: coronary artery restenosis, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: 16 OR 17 ML EVERY HOUR. During the same period patient was treated with MIDAZOLAM, FENTANYL. Patient was hospitalized. Patient died on 04/07/2008.

Reopro Side Effects Report #5740077-4
Reopro side effect was reported by a Physician from MEXICO on May 13, 2008. Male patient, 50 years of age, was diagnosed with coronary angioplasty and was treated with Reopro. After drug was administered, patient experienced the following side effects: coronary artery restenosis, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: unknown. During the same period patient was treated with MIDAZOLAM, FENTANYL CITRATE. Patient was hospitalized. Patient died on 04/07/2008.

Reopro Side Effects Report #5750426-9
Reopro side effect was reported by a Physician from MEXICO on Apr 10, 2008. Male patient, 50 years of age, was diagnosed with coronary angioplasty and was treated with Reopro. After drug was administered, patient experienced the following side effects: coronary artery restenosis, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: unknown. During the same period patient was treated with MIDAZOLAM, FENTANYL. Patient was hospitalized. Patient died on 04/07/2008.


Reopro Side Effects Report #5750427-0
Reopro side effect was reported by a Physician from MEXICO on Apr 10, 2008. Male patient, 50 years of age, was diagnosed with coronary angioplasty and was treated with Reopro. After drug was administered, patient experienced the following side effects: coronary artery restenosis, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: unknown. During the same period patient was treated with MIDAZOLAM, FENTANYL. Patient was hospitalized. Patient died on 04/07/2008.

Reopro Side Effects Report #5787036-3
Reopro side effect was reported by a Physician from MEXICO on June 23, 2008. Male patient, 50 years of age, was diagnosed with coronary angioplasty and was treated with Reopro. After drug was administered, patient experienced the following side effects: coronary artery restenosis, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: unknown. During the same period patient was treated with MIDAZOLAM, FENTANYL. Patient was hospitalized. Patient died on 04/07/2008.

Reopro Side Effects Report #5740078-6
Reopro side effect was reported by a Physician from MEXICO on May 13, 2008. Male patient, 47 years of age, weighting 198.4 lb, was treated with Reopro. After drug was administered, patient experienced the following side effects: mouth haemorrhage, musculoskeletal chest pain, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: 17 ML/HR, THEN INCREASING TO 24 ML/HR UP TO 28 ML/HR. During the same period patient was treated with HEPARIN, FENTANYL CITRATE, MIDAZOLAM. Patient was hospitalized. Patient died on 04/28/2008.

Reopro Side Effects Report #5750428-2
Reopro side effect was reported by a Physician from MEXICO on Apr 30, 2008. Male patient, 47 years of age, weighting 198.4 lb, was treated with Reopro. After drug was administered, patient experienced the following side effects: mouth haemorrhage, musculoskeletal chest pain, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: 17 ML/HR, THEN INCREASING TO 24 ML/HR UP TO 28 ML/HR. During the same period patient was treated with HEPARIN, FENTANYL, MIDAZOLAM. Patient was hospitalized. Patient died on 04/28/2008.

Reopro Side Effects Report #5750429-4
Reopro side effect was reported by a Physician from MEXICO on Apr 30, 2008. Male patient, 47 years of age, weighting 198.4 lb, was treated with Reopro. After drug was administered, patient experienced the following side effects: mouth haemorrhage, musculoskeletal chest pain, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: 17 ML/HR, THEN INCREASING TO 24 ML/HR UP TO 28 ML/HR. During the same period patient was treated with HEPARIN, FENTANYL, MIDAZOLAM. Patient was hospitalized. Patient died on 04/28/2008.


Reopro Side Effects Report #5756480-2
Reopro side effect was reported by a Physician from MEXICO on May 28, 2008. Male patient, 47 years of age, weighting 198.4 lb, was treated with Reopro. After drug was administered, patient experienced the following side effects: mouth haemorrhage, musculoskeletal chest pain, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: 17 ML/HR, THEN INCREASING TO 24 ML/HR UP TO 28 ML/HR. During the same period patient was treated with HEPARIN, FENTANYL TRANSDERMAL SYSTEM, MIDAZOLAM. Patient was hospitalized. Patient died on 04/28/2008.

Reopro Side Effects Report #5787035-1
Reopro side effect was reported by a Physician from MEXICO on June 23, 2008. Male patient, 47 years of age, weighting 198.4 lb, was treated with Reopro. After drug was administered, patient experienced the following side effects: mouth haemorrhage, musculoskeletal chest pain, myocardial infarction, pharmaceutical product counterfeit. Reopro dosage: 17 ML/HR, THEN INCREASING TO 24 ML/HR UP TO 28 ML/HR. During the same period patient was treated with HEPARIN, FENTANYL, MIDAZOLAM. Patient was hospitalized. Patient died on 04/28/2008.